ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

House panel examines use of grant funds.

September 23, 2005

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001